CAS: 862507-23-1
LY2228820
CAS:862507-23-1
Formula:
C26H37FN6O6S2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
612.7370
Ref: IN-DA00GU43
| 5mg | 111.00 € | ||
| 25mg | 151.00 € | ||
| 50mg | 179.00 € | ||
| 100mg | 217.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ralimetinib dimesylate
CAS:862507-23-1
Ralimetinib dimesylate (LY2228820 dimesylate) is a orally available, p38 MAPK inhibitor with potential anti-inflammatory and …
Formula:
C24H29FN6·2CH4O3S
Purity:
98% - 99.38%
Color and Shape:
Solid
Molecular weight:
612.74
Ref: TM-T6047
| 1mg | 41.00 € | ||
| 5mg | 83.00 € | ||
| 10mg | 128.00 € | ||
| 25mg | 236.00 € | ||
| 50mg | 361.00 € | ||
| 100mg | 462.00 € | ||
| 1mL*10mM (DMSO) | 99.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Ref: 54-BISN0222
| 1mg | 99.00 € | ||
| 5mg | 188.00 € | ||
| 10mg | 285.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
LY 2228820
Controlled ProductCAS:862507-23-1
Formula:
C24H29FN6
Color and Shape:
Neat
Molecular weight:
420.526
Ref: TR-L486500
| 250mg | 10,963.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
LY 2228820 dimesylate
CAS:862507-23-1
Inhibitor of p38 mitogen-activated protein kinase
Formula:
C26H37FN6O6S2
Purity:
Min. 95%
Molecular weight:
612.74 g/mol
Ref: 3D-FL24961
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
